August 14, 2021
5 min watch
Save
VIDEO: Screening for PAH, ILD paramount in scleroderma
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this Healio Video Perspective from the AWIR Annual Conference, Janet Pope, MD, professor of medicine, epidemiology and biostatistics at Western Bone and Joint Institute in Ontario, Canada, shares three important points from her session on pulmonary arterial hypertension and interstitial lung disease in scleroderma.
Published by:
Sources/Disclosures
Collapse
Source:
Pope J. PAH-ILD and rheumatic disease. Presented at: AWIR National Conference; August 12-15, 2021; Hilton Head, SC (hybrid meeting).
Disclosures:
Pope reports consulting and speaking for Boehringer Ingelheim and Janssen.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.